Publication | Open Access
Immune checkpoint inhibitors (IC) induce paradoxical progression in a subset of non-small cell lung cancer (NSCLC)
15
Citations
0
References
2016
Year
Cancer ImmunosurveillanceMedicineImmune Checkpoint InhibitorsImmunologyPathologyParadoxical ProgressionBronchial NeoplasmImmune Checkpoint InhibitorLung CancerImmunotherapyOncologyTumor MicroenvironmentTumor Biology
No additional data available for this publication yet. Check back later!